— Know what they know.
Not Investment Advice

MRRCF OTC

Wayland Group Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +900.0% 1Y: +0.0% 3Y: +900.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $2121 mcap · 197M float · 0.0006% daily turnover

Cash Flow Trends

Operating Cash Flow
-$16M -308.3% ▼
Capital Expenditures
$15M -492.3% ▼
Free Cash Flow
-$32M -379.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$8M -37.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2015FY2016FY2017
— Operating Activities —
Net Income-$73K-$6M-$52M
Depreciation & Amort.$0$530K$1M
Stock-Based Comp.$0$0$0
Change in Working Capital-$54K$2M-$780K
Other Non-Cash Items$30K$732K$37M
Operating Cash Flow-$97K-$4M-$16M
— Investing Activities —
Capital Expenditures$0-$3M-$15M
Acquisitions (Net)$0$0-$1M
Investment Purchases$0$0-$290K
Investment Sales$0$0$0
Other Investing$0$0$0
Investing Cash Flow$0-$3M-$17M
— Financing Activities —
Net Debt Issuance$432K$16M$22M
Stock Repurchased$0$0$0
Dividends Paid$0$0$0
Other Financing-$3M$0$0
Financing Cash Flow$96K$19M$40M
Net Change in Cash-$456$12M$8M
Cash End of Period-$456$12M$20M
Free Cash Flow-$97K-$7M-$32M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms